KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Current Assets (2016 - 2026)

Pacific Biosciences Of California has reported Current Assets over the past 16 years, most recently at $375.1 million for Q4 2025.

  • For Q4 2025, Current Assets fell 24.34% year-over-year to $375.1 million; the TTM value through Dec 2025 reached $375.1 million, down 24.34%, while the annual FY2025 figure was $375.1 million, 24.34% down from the prior year.
  • Current Assets for Q4 2025 was $375.1 million at Pacific Biosciences Of California, down from $394.2 million in the prior quarter.
  • Over five years, Current Assets peaked at $1.2 billion in Q1 2021 and troughed at $375.1 million in Q4 2025.
  • A 5-year average of $779.2 million and a median of $852.1 million in 2022 define the central range for Current Assets.
  • Biggest five-year swings in Current Assets: surged 687.83% in 2021 and later crashed 34.28% in 2025.
  • Year by year, Current Assets stood at $1.1 billion in 2021, then fell by 22.62% to $852.1 million in 2022, then decreased by 12.91% to $742.0 million in 2023, then tumbled by 33.2% to $495.7 million in 2024, then decreased by 24.34% to $375.1 million in 2025.
  • Business Quant data shows Current Assets for PACB at $375.1 million in Q4 2025, $394.2 million in Q3 2025, and $413.4 million in Q2 2025.